These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14994420)

  • 1. Macrophage activation syndrome and etanercept in children with systemic juvenile rheumatoid arthritis.
    Sawar H; Espinoza LR; Gedalia A
    J Rheumatol; 2004 Mar; 31(3):623; author reply 623-4. PubMed ID: 14994420
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.
    Ramanan AV; Schneider R
    J Rheumatol; 2003 Feb; 30(2):401-3. PubMed ID: 12563702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis.
    Nádia EA; Carvalho JF; Bonfá E; Lotito AP; Silva CA
    Isr Med Assoc J; 2009 Oct; 11(10):635-6. PubMed ID: 20077954
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophage activation syndrome after etanercept treatment.
    Sandhu C; Chesney A; Piliotis E; Buckstein R; Koren S
    J Rheumatol; 2007 Jan; 34(1):241-2. PubMed ID: 17216706
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis.
    Bout-Tabaku S; Rivas-Chacon R; Restrepo R
    J Rheumatol; 2007 Dec; 34(12):2503-4. PubMed ID: 18061971
    [No Abstract]   [Full Text] [Related]  

  • 6. Etanercept therapy in children with juvenile rheumatoid arthritis.
    Hung JJ; Huang JL
    J Microbiol Immunol Infect; 2005 Dec; 38(6):444-6. PubMed ID: 16341346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
    Kimura Y; Pinho P; Walco G; Higgins G; Hummell D; Szer I; Henrickson M; Watcher S; Reiff A
    J Rheumatol; 2005 May; 32(5):935-42. PubMed ID: 15868633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
    Lai JH
    J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348
    [No Abstract]   [Full Text] [Related]  

  • 9. Optic neuritis associated with etanercept therapy in two patients with extended oligoarticular juvenile idiopathic arthritis.
    Tauber T; Daniel D; Barash J; Turetz J; Morad Y
    Rheumatology (Oxford); 2005 Mar; 44(3):405. PubMed ID: 15637094
    [No Abstract]   [Full Text] [Related]  

  • 10. The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm.
    Szyper-Kravitz M
    Isr Med Assoc J; 2009 Oct; 11(10):633-4. PubMed ID: 20077953
    [No Abstract]   [Full Text] [Related]  

  • 11. Psoriasis after treatment of juvenile idiopathic arthritis with etanercept.
    Peek R; Scott-Jupp R; Strike H; Clinch J; Ramanan AV
    Ann Rheum Dis; 2006 Sep; 65(9):1259. PubMed ID: 16905590
    [No Abstract]   [Full Text] [Related]  

  • 12. Etanercept and warts.
    Adams DR; Zaenglein AL; Hershey MS
    J Drugs Dermatol; 2004; 3(6):601. PubMed ID: 15624740
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypersensitive joint reaction after etanercept treatment in a patient with juvenile rheumatoid arthritis.
    Guo MM; Yang KD; Yu HR; Kuo HC
    J Rheumatol; 2011 Mar; 38(3):577-9. PubMed ID: 21362794
    [No Abstract]   [Full Text] [Related]  

  • 14. Etanercept in the treatment of macrophage activation syndrome.
    Prahalad S; Bove KE; Dickens D; Lovell DJ; Grom AA
    J Rheumatol; 2001 Sep; 28(9):2120-4. PubMed ID: 11550985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis.
    Hagiwara K; Sato T; Takagi-Kobayashi S; Hasegawa S; Shigihara N; Akiyama O
    J Rheumatol; 2007 May; 34(5):1151-4. PubMed ID: 17444583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis.
    Smith JA; Thompson DJ; Whitcup SM; Suhler E; Clarke G; Smith S; Robinson M; Kim J; Barron KS
    Arthritis Rheum; 2005 Feb; 53(1):18-23. PubMed ID: 15696578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
    Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Ravelli A; Caria MC; Buratti S; Malattia C; Temporini F; Martini A
    J Rheumatol; 2001 Apr; 28(4):865-7. PubMed ID: 11327264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept-induced encephalopathy in a 7-year-old child.
    Ekici B; Aydın K; Cantez S; Ergül Y; Tatlı B
    Pediatr Neurol; 2011 Oct; 45(4):271-3. PubMed ID: 21907894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activation syndrome induced by etanercept in a patient with systemic sclerosis.
    Sterba G; Sterba Y; Stempel C; Blank J; Azor E; Gomez L
    Isr Med Assoc J; 2010 Jul; 12(7):443-5. PubMed ID: 20862830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.